Edition:
United States

aTyr Pharma Inc (LIFE.OQ)

LIFE.OQ on NASDAQ Stock Exchange Global Select Market

0.89USD
17 Jul 2018
Change (% chg)

$-0.02 (-1.99%)
Prev Close
$0.91
Open
$0.90
Day's High
$0.92
Day's Low
$0.89
Volume
35,765
Avg. Vol
77,206
52-wk High
$6.45
52-wk Low
$0.83

Chart for

About

aTyr Pharma, Inc. is a clinical-stage biotherapeutics company. The Company is engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using its Physiocrine biology, a discovered set of physiological modulators. The Company focuses on the development of Physiocrine-based... (more)

Overall

Beta: --
Market Cap(Mil.): $28.04
Shares Outstanding(Mil.): 29.83
Dividend: --
Yield (%): --

Financials

  LIFE.OQ Industry Sector
P/E (TTM): -- 214.90 33.15
EPS (TTM): -1.69 -- --
ROI: -71.81 -3.85 13.23
ROE: -86.44 -5.38 15.27

BRIEF-Atyr Pharma Inc Posts Qtrly Loss Of $0.36 Per Share

* ATYR PHARMA ANNOUNCES FIRST QUARTER 2018 OPERATING RESULTS, PROGRAM PRIORITIZATION AND CORPORATE RESTRUCTURING

May 14 2018

BRIEF-Atyr Pharma Q4 Loss Per Share $0.39

* ATYR PHARMA ANNOUNCES FOURTH QUARTER AND YEAR-END 2017 OPERATING RESULTS AND PROVIDES CORPORATE UPDATE

Mar 19 2018

Earnings vs. Estimates